GlycoMimetics's market cap is currently ―. The company's EPS TTM is $-0.584; its P/E ratio is -3.08; GlycoMimetics is scheduled to report earnings on May 2, 2024, and the estimated EPS forecast is $-0.14. See an overview of income statement, balance sheet, and cash flow financials.

	Dec 23	Sep 23	Jun 23	Mar 23	Dec 22
Income Statement	-
Total Revenue	$ 10.00K	-	-	-	-
Gross Profit	$ 10.00K	-	-	-	-
EBIT	$ -9.08M	$ -9.20M	$ -8.26M	$ -10.36M	$ -10.62M
EBITDA	$ -8.87M	$ -8.93M	$ -7.99M	$ -10.10M	$ -10.36M
Net Income Common Stockholders	$ -9.08M	$ -9.20M	$ -8.26M	$ -10.36M	$ -10.24M
Balance Sheet	-
Cash, Cash Equivalents and Short-Term Investments	$ 41.80M	$ 49.41M	$ 58.04M	$ 65.00M	$ 47.87M
Total Assets	$ 45.32M	$ 53.20M	$ 61.82M	$ 68.67M	$ 51.76M
Total Debt	$ 808.40K	$ 1.01M	$ 1.27M	$ 651.73K	$ 918.55K
Net Debt	$ -40.99M	$ -48.40M	$ -56.77M	$ -64.35M	$ -46.95M
Total Liabilities	$ 6.90M	$ 6.65M	$ 7.02M	$ 6.79M	$ 8.93M
Stockholders Equity	$ 38.41M	$ 46.55M	$ 54.80M	$ 62.23M	$ 42.92M
Cash Flow	-
Free Cash Flow	$ -7.64M	$ -8.69M	$ -6.99M	$ -11.61M	$ -7.91M
Operating Cash Flow	$ -7.64M	$ -8.68M	$ -6.97M	$ -11.61M	$ -7.91M
Investing Cash Flow	$ -801.00	$ -7.87K	$ -10.53K	$ -2.20K	$ -1.00
Financing Cash Flow	$ 999.00	$ 61.62K	$ 20.11K	$ 28.74M	$ 4.16M

Currency in USD

GlycoMimetics Earnings and Revenue History

Income Statement >

GlycoMimetics Debt to Assets

Balance Sheet >

GlycoMimetics Cash Flow

Cash Flow >

GlycoMimetics Forecast EPS vs Actual EPS

Earnings >

Get More with TipRanks Premium

What's Included in PREMIUM?

Make informed decisions based on Top Analysts' activity

Know what industry insiders are buying

Get actionable alerts from top Wall Street Analysts

Find out before anyone else which stock is going to shoot up

Get powerful stock screeners & detailed portfolio analysis

Subscribe Now See Plans & Pricing